Medical Research Finder

Loading…

© 2025 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Escherichia coli Nissle 1917 / E. coli Nissle 1917 (EcN)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Escherichia coli strain Nissle 1917 (EcN) is known to reduce Food Intake / Eating and increase Energy expenditure
Park et al. 2021a Nutrients 13: 811

It is relatively safe for therapeutic applications because it does not cause colitis
Gronbach et al. 2010 Infect. Immun. 78: 3036
Yu et al. 2019a JCI Insight. 4(16): e125166

The strain Escherichia coli Nissle 1917 / E. coli Nissle 1917 (EcN) is a non-pathogenic fecal bacterium, well studied as probiotic and exerts probiotic effects in humans and animals
Kruis et al. 1997 Aliment. Pharmacol. Ther. 11: 853-858
D’Souza…

References (Sources)

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
Kruis et al. 1997 Aliment. Pharmacol. Ther. 11: 853-858
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch et al. 2022 Trends in Pharmacological Sciences 43(9): 772
Review
Probiotic Escherichia coli Ameliorates Antibiotic-Associated Anxiety Responses in Mice
Park et al. 2021a Nutrients 13: 811
Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis.
D’Souza et al. 2002 BMJ 324: 1361
Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.
Gronbach et al. 2010 Infect. Immun. 78: 3036
Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): A retrospective survey
Plassmann & Schulte-Witte 2007 Med. Klin. 102: 888-892
Worm-Based Alternate Assessment of Probiotic Intervention against Gut Barrier Infection
Kim & Moon 2009 Nutrients 11: 2146

AI Chat

12/17/2025

Chat with our artificial intelligence: